Filing Details

Accession Number:
0001179110-20-006663
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-27 18:18:02
Reporting Period:
2020-05-22
Accepted Time:
2020-05-27 18:18:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697362 Burkes Michael Brophy C/O Natera, Inc., 201 Industrial Road
Suite 410
San Carlos CA 94070
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-22 3,251 $10.41 26,525 No 4 M Direct
Common Stock Disposition 2020-05-22 3,251 $45.45 23,274 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2020-05-22 3,251 $0.00 3,251 $10.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,387 2027-06-08 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2019.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.19 to $45.76 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.